July 2026
1. SANTOS AR, Almeida A, Pinto I, Rocha AC, et al
   Cross-device consistency in diabetic retinopathy grading: a comparative analysis of widefield versus standard 30-35 degrees - the ClarusDR study.
   Br J Ophthalmol. 2026 Jul 23:bjo-2025-329382. doi: 10.1136/bjo-2025-329382.
   

   >> Share

   
   
2. GUAN Z, Li Y, Li Y, Qian Z, et al
   Global temporal trends of DR-related blindness and vision loss from 1990 to 2021: an age-period-cohort analysis of the contributions of type 1 and type 2 diabetes.
   Br J Ophthalmol. 2026 Jul 20:bjo-2025-328581. doi: 10.1136/bjo-2025-328581.
   

   >> Share

   
   
3. LIN Z, Zheng W, Ding X, Liu B, et al
   Microinvasive pars plana vitrectomy versus panretinal photocoagulation for severe non-proliferative diabetic retinopathy: a randomised controlled trial.
   Br J Ophthalmol. 2026 Jul 17:bjo-2025-328536. doi: 10.1136/bjo-2025-328536.
   

   >> Share

   
   June 2026
4. GIL O, Arad A, Fogel M, Vorobichik-Berar O, et al
   Real-world integration of an autonomous artificial intelligence system for diabetic retinopathy screening in an endocrinology outpatient clinic.
   Br J Ophthalmol. 2026 Jun 29:bjo-2025-328991. doi: 10.1136/bjo-2025-328991.
   

   >> Share

   
   
5. VIGGIANO P, Peto T, Pignataro M, Termite AC, et al
   Proactive treatment regimen with dexamethasone implant for diabetic and post-occlusive macular oedema: the ProDEX-2 study.
   Br J Ophthalmol. 2026 Jun 5:bjo-2025-328550. doi: 10.1136/bjo-2025-328550.
   

   >> Share

   
   
6. KHALID H, Tsai WS, Lamanna F, Riotto E, et al
   Quantification of retinal non-perfusion in eyes with diabetic retinopathy to study the association with retinal neovascularisation: INSPIRED study report 3.
   Br J Ophthalmol. 2026 Jun 4:bjo-2025-329361. doi: 10.1136/bjo-2025-329361.
   

   >> Share

   
   May 2026
7. CAO D, Tan R, Goh RA, Yang Q, et al
   Peripheral retinal haemorrhage density on ultra-widefield imaging as a novel biomarker for predicting diabetic retinopathy progression: a 2-year longitudinal study in Asians.
   Br J Ophthalmol. 2026 May 12:bjo-2025-327940. doi: 10.1136/bjo-2025-327940.
   

   >> Share

   
   
8. FRASER-BELL S, Lee NS, Hashimoto Y, Pollreisz A, et al
   Outcomes of eyes with persistent diabetic macular oedema: The Fight Retinal Blindness! Project.
   Br J Ophthalmol. 2026 May 6:bjo-2025-328621. doi: 10.1136/bjo-2025-328621.
   

   >> Share

   
   
9. RUIZ BILBAO S, Mas Casals A, Gomez Sanchez S, Diaz-Aljaro P, et al
   Cost-effectiveness of OCT-enhanced screening for diabetic retinopathy: a 50-year Markov model analysis in type 2 diabetes.
   Br J Ophthalmol. 2026 May 5:bjo-2025-327884. doi: 10.1136/bjo-2025-327884.
   

   >> Share

   
   April 2026
10. CHALKIADAKI E, Sim YS, Williams O, Elder L, et al
    Real-world early outcomes of intravitreal faricimab 6-mg and aflibercept 2-mg injection in diabetic macular oedema.
    Br J Ophthalmol. 2026 Apr 21:bjo-2025-328893. doi: 10.1136/bjo-2025-328893.
    

    >> Share

    
    
11. LIU Y, Huang J, Ao M, Huang Y, et al
    Real-world effect of vitrectomy combined with intravitreal conbercept for treatment of vitreous haemorrhage in proliferative diabetic retinopathy (QILIN I): a prospective cohort study.
    Br J Ophthalmol. 2026 Apr 15:bjo-2025-329066. doi: 10.1136/bjo-2025-329066.
    

    >> Share

    
    January 2026
12. FRANQUESA-GARCIA F, Romero-Nunez B, Martin-Pinardel R, De Zanet S, et al
    Artificial intelligence-based fluid quantification predicts clinical outcomes in diabetic macular oedema eyes treated with intravitreal dexamethasone implants: DIADEMA project.
    Br J Ophthalmol. 2026 Jan 16:bjo-2025-328172. doi: 10.1136/bjo-2025-328172.
    

    >> Share

    
    November 2025
13. CHOE S, Xi C, Park DY, Kang KH, et al
    Synergistic effects of glaucoma, degeneration of macula and posterior pole, and diabetic ophthalmic complications on vision loss.
    Br J Ophthalmol. 2025 Nov 17:bjo-2025-327643. doi: 10.1136/bjo-2025-327643.
    

    >> Share

    
    October 2025
14. XU X, Zhang J, Song X, Liu X, et al
    Enhancing diabetic retinopathy diagnosis and grading: a retrospective study on AI-assisted decision making and cost analysis.
    Br J Ophthalmol. 2025 Oct 20:bjo-2025-327442. doi: 10.1136/bjo-2025-327442.
    

    >> Share

    
    August 2025
15. JOSEPH S, Wang Y, Drinkwater JJ, Jan CL, et al
    Effectiveness of artificial intelligence-based diabetic retinopathy screening in primary care and endocrinology settings in Australia: a pragmatic trial.
    Br J Ophthalmol. 2025 Aug 22:bjo-2025-327447. doi: 10.1136/bjo-2025-327447.
    

    >> Share

    
    July 2025
16. KIM SJ, Gangaputra S, Sheng J, Patel S, et al
    Analysis of 24 pro-inflammatory cytokines in aqueous and serum of 94 patients without diabetes.
    Br J Ophthalmol. 2025 Jul 22:bjo-2025-327421. doi: 10.1136/bjo-2025-327421.
    

    >> Share

    
    
17. HASHIMOTO Y, Hunt AR, Silva R, Witmer A, et al
    Differentiating treatment episodes from gaps in eyes with diabetic macular oedema.
    Br J Ophthalmol. 2025 Jul 1:bjo-2025-327238. doi: 10.1136/bjo-2025-327238.
    

    >> Share

    
    June 2025
18. WU H, Su Z, Pan X, Shao A, et al
    Enhancing diabetic retinopathy query responses: assessing large language model in ophthalmology.
    Br J Ophthalmol. 2025 Jun 30:bjo-2024-325861. doi: 10.1136/bjo-2024-325861.
    

    >> Share

    
    
19. PANDEY PU, Micieli JA, Ong Tone S, Eng KT, et al
    Realistic fundus photograph generation for improving automated disease classification.
    Br J Ophthalmol. 2025;109:791-798.
    

    >> Share

    
    May 2025
20. RUIZ-MEDRANO J, Udaondo Mirete P, Fernandez-Jimenez M, Asencio-Duran M, et al
    Biomarkers of risk of switching to dexamethasone implant for the treatment of diabetic macular oedema in real clinical practice: a multicentric study.
    Br J Ophthalmol. 2025 May 16:bjo-2024-325665. doi: 10.1136/bjo-2024-325665.
    

    >> Share

    
    
21. LIU Z, Huang Y, Jin L, Pan C, et al
    Validation of a self-administered Home ETDRS visual acuity testing (H-ETDRS) for self-monitoring vision changes in retinal diseases.
    Br J Ophthalmol. 2025 May 10:bjo-2024-326283. doi: 10.1136/bjo-2024-326283.
    

    >> Share

    
    March 2025
22. LEE WA, Shao SC, Hsieh MH, Liao TC, et al
    Adverse renal events between ranibizumab and aflibercept in patients with diabetic macular oedema in Taiwan: a comparative cohort study.
    Br J Ophthalmol. 2025 Mar 27:bjo-2024-325509. doi: 10.1136/bjo-2024-325509.
    

    >> Share

    
    
23. ZHANG W, Cheng S, Gu X, Liu X, et al
    Simultaneous inhibition of fibroblast growth factor-2 and vascular endothelial growth factor-a with RC28-E in diabetic macular edema: a phase 2 randomised trial.
    Br J Ophthalmol. 2025 Mar 23:bjo-2024-326006. doi: 10.1136/bjo-2024-326006.
    

    >> Share

    
    February 2025
24. DANIELI L, Midena G, Frizziero L, Midena E, et al
    Disorganisation of inner retinal layers in diabetic macular oedema: is it time to standardise this OCT biomarker?
    Br J Ophthalmol. 2025 Feb 27:bjo-2024-326843. doi: 10.1136/bjo-2024-326843.
    

    >> Share

    
    
25. CAO J, Su T, Chen S, Du Z, et al
    Evaluating lipid-lowering drug targets for full-course diabetic retinopathy.
    Br J Ophthalmol. 2025 Feb 3:bjo-2024-325771. doi: 10.1136/bjo-2024-325771.
    

    >> Share

    
    November 2024
26. PARIS A, Volpe G, Perruchoud-Ader K, Casanova A, et al
    Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study.
    Br J Ophthalmol. 2024 Nov 12:bjo-2024-326053. doi: 10.1136/bjo-2024-326053.
    

    >> Share

    
    August 2024
27. ZHONG X, Yang S, Zhu Z, Li H, et al
    Trajectories of choriocapillaris perfusion in healthy individuals and patients with diabetes mellitus: a prospective cohort study.
    Br J Ophthalmol. 2024 Aug 28:bjo-2024-325515. doi: 10.1136/bjo-2024-325515.
    

    >> Share

    
    May 2024
28. ZHONG P, Yang S, Liu R, Zhu Z, et al
    Handgrip strength and risks of diabetic vascular complications: Evidence from Guangzhou Diabetic Eye Study and UK cohorts.
    Br J Ophthalmol. 2024 May 30:bjo-2023-324893. doi: 10.1136/bjo-2023-324893.
    

    >> Share

    
    
29. BRESSLER I, Aviv R, Margalit D, Rom Y, et al
    Autonomous screening for laser photocoagulation in fundus images using deep learning.
    Br J Ophthalmol. 2024;108:742-746.
    

    >> Share

    
    
30. JIN G, Ma Y, Zheng D, Jin L, et al
    Evaluation of systemic medications associated with diabetic retinopathy: a nested case-control study from the UK Biobank.
    Br J Ophthalmol. 2024 May 20:bjo-2023-324930. doi: 10.1136/bjo-2023-324930.
    

    >> Share

    
    
31. CHEONG KX, Zhang C, Tan TE, Fenner BJ, et al
    Comparing generative and retrieval-based chatbots in answering patient questions regarding age-related macular degeneration and diabetic retinopathy.
    Br J Ophthalmol. 2024 May 15:bjo-2023-324533. doi: 10.1136/bjo-2023-324533.
    

    >> Share

    
    
32. VINGOPOULOS F, Baldwin G, Katz R, Cui Y, et al
    Associations of quantitative contrast sensitivity with vascular metrics on widefield swept-source OCT angiography across stages of diabetic retinopathy.
    Br J Ophthalmol. 2024 May 6:bjo-2023-323900. doi: 10.1136/bjo-2023-323900.
    

    >> Share

    
    February 2024
33. MELLOR J, Jiang W, Fleming A, McGurnaghan SJ, et al
    Prediction of retinopathy progression using deep learning on retinal images within the Scottish screening programme.
    Br J Ophthalmol. 2024 Feb 5:bjo-2023-323400. doi: 10.1136/bjo-2023-323400.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share